Skip Navigation

Independently Verified: Low Shear, Low Pulsation, Proven Performance for Biopharmaceutical Processing

When processing sensitive biologics or cell therapies, ensuring product integrity is paramount. We understand that BioPharmaceutical companies need data driven results to feel confident that the technology they use, can protect the integrity of their delicate pharmaceutical formulations. That’s why Fristam sought to independently test our double screw technology on sensitive blood cell cultures at the bioX laboratories and share the results with our customers.

Our whitepaper details the full methodology of testing and shares results and comparative insights on: mechanical shear, hemolysis, IgG denaturation and more.

To download the complete bioX Applications Lab report now, please leave some brief details: